BractonDeal Intel
Get full access
AcquisitionFinTech

Gurnet Point Capital acquired Paratek Pharmaceuticals, Inc.

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Gurnet Point Capital -> Paratek Pharmaceuticals, Inc. · $3.00

The upfront payment at closing represents a premium of 41% over the closing price of Paratek’s common stock as of May 31, 2023, which was the last full trading day prior to market speculation regarding a potential sale of the company.

Open source record (SEC) ↗